AlphaCentric Advisors’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

AlphaCentric Advisors’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-108,500	Closed	-$3.12M	–	244
2024 Q3	$3.12M	Hold	108,500	–	–	2.32%	3
2024 Q2	$2.69M	Buy	108,500 +3,500	+3%	+$99.3K	1.98%	8
2024 Q1	$3.38M	Hold	105,000	–	–	2.04%	7
2023 Q4	$4.27M	Hold	105,000	–	–	2.87%	2
2023 Q3	$3.63M	Buy	105,000 +6,000	+6%	+$234K	2.06%	6
2023 Q2	$4.03M	Buy	99,000 +7,000	+8%	+$286K	2.23%	4
2023 Q1	$3.55M	Buy	92,000 +49,500	+116%	+$2.03M	2.45%	3
2022 Q4	$1.89M	Buy	42,500 +12,500	+42%	+$526K	1.86%	7
2022 Q3	$1.28M	Buy	+30,000	New	+$1.54M	1.31%	14
2021 Q4	$1.71M	Buy	31,000 +1,500	+5%	+$78.3K	0.5%	10
2021 Q3	$1.55M	Buy	29,500 +8,000	+37%	+$475K	0.39%	10
2021 Q2	$1.48M	Buy	21,500 +4,500	+26%	+$343K	0.4%	11
2021 Q1	$1.31M	Buy	17,000 +14,600	+608%	+$1.34M	0.44%	11
2020 Q4	$238K	Buy	+2,400	New	+$293K	0.1%	58

Other funds holding LKFT

Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

AlphaCentric Advisors's LKFT Position: Q4 2024 in Review

AlphaCentric Advisors sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q4 2024, closing a stake of 108,500 shares — an estimated $3.12M sold.

AlphaCentric Advisors first reported a position in LKFT in Q4 2020 and held it in 14 quarters. The position peaked at $4.27M in Q4 2023. 81 funds tracked by Wall St. Rank hold LKFT as of Q4 2024.

AlphaCentric Advisors reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q4 2024 after selling out during the quarter.
AlphaCentric Advisors sold 108,500 Lakefront Biotherapeutics American Depositary Shares shares in Q4 2024, an estimated $3.12M.
AlphaCentric Advisors first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2020 and held it in 14 quarters.
AlphaCentric Advisors's Lakefront Biotherapeutics American Depositary Shares position peaked at $4.27M in Q4 2023.
81 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q4 2024.

Based on AlphaCentric Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.